TScan Therapeutics Q3 2024 Update
Ticker: TCRX · Form: 10-Q · Filed: 2024-11-12T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, biotech, financials, stock-offering
TL;DR
TScan Therapeutics filed its 10-Q for Q3 2024, showing revenue and stock activity. Key dates: 04/24/2024.
AI Summary
TScan Therapeutics, Inc. reported its financial results for the period ending September 30, 2024. The company's revenue from collaborations and licenses is detailed, with specific figures not immediately available in this snippet but indicated by URLs. The filing also references stock transactions, including a follow-on offering on April 24, 2024, and employee stock purchase plans.
Why It Matters
This filing provides insight into TScan Therapeutics' financial health and ongoing business activities, which can influence investor decisions and market perception.
Risk Assessment
Risk Level: medium — The company is in the biotechnology sector, which is inherently high-risk due to R&D costs and regulatory hurdles, though specific financial distress is not indicated.
Key Numbers
- N/A — Collaboration and License Revenue (Specific dollar amounts not provided in this snippet, but indicated by URLs.)
- 2024-04-24 — Follow-on Offering (Date of a significant stock offering.)
Key Players & Entities
- TScan Therapeutics, Inc. (company) — Filer
- 0000950170-24-124575 (other) — Accession Number
- 20240930 (date) — Reporting Period End Date
- 20241112 (date) — Filing Date
- 2024-04-24 (date) — Follow-on Offering Date
FAQ
What was TScan Therapeutics' total revenue for the quarter ending September 30, 2024?
The provided text snippet does not contain the specific dollar amount for total revenue for the quarter ending September 30, 2024, but it does reference URLs related to 'CollaborationAndLicenseRevenue'.
When did TScan Therapeutics conduct its most recent follow-on offering?
TScan Therapeutics conducted a follow-on offering on April 24, 2024.
What is TScan Therapeutics' fiscal year end?
TScan Therapeutics' fiscal year ends on December 31.
What is the company's primary business classification?
The company's Standard Industrial Classification is 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.
What is the company's principal business address?
The company's principal business address is 880 WINTER STREET, WALTHAM, MA 02451.
From the Filing
0000950170-24-124575.txt : 20241112 0000950170-24-124575.hdr.sgml : 20241112 20241112073035 ACCESSION NUMBER: 0000950170-24-124575 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 241443307 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 10-Q 1 tcrx-20240930.htm 10-Q 10-Q --12-31 false 0001783328 Q3 http://www.tscan.com/20240930#CollaborationAndLicenseRevenue http://www.tscan.com/20240930#CollaborationAndLicenseRevenue http://www.tscan.com/20240930#CollaborationAndLicenseRevenue http://www.tscan.com/20240930#CollaborationAndLicenseRevenue March 31 2020 827 462 827 0001783328 tcrx:VotingCommonStockMember tcrx:WedbushSecuritiesIncMember tcrx:SalesAgreementMember 2023-05-16 2024-09-30 0001783328 tcrx:EmployeeStockPurchasePlanMember 2024-01-01 2024-09-30 0001783328 tcrx:VotingCommonStockMember tcrx:FollowOnOfferingMember 2024-04-24 2024-04-24 0001783328 2023-01-01 2023-12-31 0001783328 tcrx:K2HealthVenturesMember srt:MinimumMember 2024-09-30 0001783328 us-gaap:MoneyMarketFundsMember 2023-12-31 0001783328 tcrx:VotingCommonStockMember tcrx:PreFundedWarrantsMember 2024-04-24 0001783328 us-gaap:CommonStockMember tcrx:VotingCommonStockMember 2024-01-01 2024-09-30 0001783328 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001783328 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001783328 tcrx:VotingCommonStockMember us-gaap:IPOMember 2023-06-01 0001783328 tcrx:JasonAmelloMember 2024-09-30 0001783328 2024-04-24 2024-04-24 0001783328 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001783328 us-gaap:NonvotingCommonStockMember us-gaap:CommonStockMember 2023-06-30 0001783328 us-gaap:NonvotingCommonStockMember us-gaap:CommonStockMember 2023-12-31 0001783328 2024-06-30 0001783328 us-gaap:RetainedEarningsMember 2022-12-31 0001783328 us-gaap:RetainedEarningsMember 2023-09-30 0001783328 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001783328 tcrx:VotingCommonStockMember 2024-09-30 0001783328 us-gaap:CommonStockMember tcrx:VotingCommonStockMember 2023-12-31 0001783328 tcrx:VotingCommonStockMember 2023-12-31 0001783328 us-gaap:RetainedEarningsMember 2023-12-31 0001783328 2023-09-30 0001783328 us-gaap:CommonStockMember tcrx:VotingCommonStockMember 2024-09-30 0001783328 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001783328 us-gaap:RetainedEarningsMember 2024-06-30 0001783328 tcrx:VotingCommonStockMember tcrx:FollowOnOfferingMember 2024-04-24 0001783328 tcrx:VotingCommonStockMember 2024-11-07 0001783328 us-gaap:NonvotingCommonStockMember us-gaap:CommonStockMember 2024-06-30 0001783328 2022-12-31 0001783328 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001783328 us-gaap:CommonStockMember tcrx:VotingCommonStockMember 2024-07-01 2024-09-30 0001783328 tcrx:K2HealthVenturesMember 2022-09-09 0001783328 us-gaap:RetainedEarningsMember 2023-06-30 0001783328 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2024-09-30 0001783328 tcrx:K2HealthVenturesMember tcrx:TrancheTwoMember 2022-09-09 0001783328 2023-01-01 2023-09-30 0001783328 2023-12-31 0001783328 us-gaap:SubsequentEventMember 2024-10-28 0001783328 us-gaap:NonvotingCommonStockMember us-gaap:CommonStockMember 2023-09-30 0001783328 tcrx:K2HealthVenturesMember 2022-09-09 2022-09-09 0001783328 us-gaap:CommonStockMember tcrx:VotingCommonStockMember 2023-06-30 0001783328 tcrx:K2HealthVenturesMember srt:MaximumMember